Ally Bridge Group »

Capricor Therapeutics shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.5M 114k 30.40

More positions owned by Ally Bridge Group

Soleno Therapeutics (SLNO)
Praxis Precision Medicines I Com New (PRAX)
Minerva Neurosciences Com New (NERV)
Ovid Therapeutics (OVID)
Compass Pathways Sponsored Ads (CMPS)
Tarsus Pharmaceuticals (TARS)
Solid Biosciences Com New (SLDB)
Compass Therapeutics Call Option (CMPX)
Promis Neurosciences Com Shs (PMN)
Edgewise Therapeutics (EWTX)
Uniqure Nv SHS Call Option (QURE)
Eupraxia Pharmaceuticals (EPRX)
Cytomx Therapeutics (CTMX)
Inventiva Sa Ads (IVA)
Perspective Therapeutics Com New (CATX)

View all positions for Ally Bridge Group

Top funds holding Capricor Therapeutics

Suvretta Capital Management
BlackRock
Tang Capital Management
Susquehanna International
Vanguard Group
Vanguard Capital Management
RA Capital Management
Citadel Advisors
Geode Capital Management
Jane Street
FMR
Goldman Sachs Group
Jones Hill Capital
Ikarian Capital
J. Goldman & Co

View all funds holding Capricor Therapeutics